Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000198887 | SCV000252982 | likely benign | Ataxia-telangiectasia syndrome | 2023-12-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000218293 | SCV000276284 | likely benign | Hereditary cancer-predisposing syndrome | 2015-06-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000218293 | SCV001339686 | likely benign | Hereditary cancer-predisposing syndrome | 2019-04-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001594869 | SCV001829857 | benign | not provided | 2015-07-13 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589861 | SCV005085671 | benign | Familial cancer of breast | 2024-06-14 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Ce |
RCV001594869 | SCV005330049 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | ATM: BP4, BP7 |